Dermapharm Holding SE
€38.55+€0.35 (+0.92%)
Dermapharm Holding SE’s quoted price sits in the lower half of its reported 52-week range, 25.72% below the high.
XETRA · FAA.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Fabasoft AG’s quoted price sits in the upper half of its reported 52-week range, 10.86% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fabasoft AG’s forward annual dividend is €0.50 per share, paid annual. The forward yield is 3.13% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Fabasoft AG’s next earnings report is currently expected on Nov 13, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fabasoft AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1988 and headquartered in Linz, Austria, Fabasoft AG, through its subsidiaries, develops software products and delivers cloud-based services to both public and private sectors across Austria, Germany, Switzerland, and global markets. The company offers a comprehensive suite of solutions, including the Fabasoft eGov-Suite for electronic public sector records, and Fabasoft Folio, an on-premises system for workflow and enterprise content management. Its portfolio also features Mindbreeze InSpire, providing appliances and cloud services for advanced information insights, knowledge management, and artificial intelligence capabilities. Further specialized tools encompass Fabasoft Approve, tailored for the management of technical data and documents; the Fabasoft Business Process Cloud, designed to digitize inter-company workflows; and Xpublisher, which facilitates standardized content handling and automated multi-channel publishing. Additionally, Fabasoft provides cloud-based contract management via Fabasoft Contracts, and ensures secure digital signing processes and corporate data protection with Fabasoft Secomo. Rounding out its offerings are development and operations tools like Fabasoft app.telemetry for application performance and response time monitoring, Fabasoft app.ducx, a use-case driven development environment for business applications, and Fabasoft app.test for robust application testing.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Feb 14, 2025 |
| €0.30 |
| €22.90M0.0% vs estimate |
| Q2 2025 | Nov 8, 2024 | €0.31 | €22.10M+46.96% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€38.55+€0.35 (+0.92%)
Dermapharm Holding SE’s quoted price sits in the lower half of its reported 52-week range, 25.72% below the high.
€79.40-€1.60 (-1.98%)
All for One Group SE’s quoted price sits in the upper half of its reported 52-week range, 3.64% below the high.
€3.64-€0.10 (-2.67%)
Msg Life Ag’s quoted price sits in the lower half of its reported 52-week range, 9.0% below the high.
€13.55-€0.40 (-2.87%)
Allgeier SE’s quoted price sits in the lower half of its reported 52-week range, 44.01% below the high.
€14.30+€0.25 (+1.78%)
Serviceware SE’s quoted price sits in the lower half of its reported 52-week range, 25.52% below the high.
€15.50-€1.00 (-6.06%)
ParTec AG’s quoted price sits in the lower half of its reported 52-week range, 83.94% below the high.
PLN 22.75-PLN 0.25 (-1.09%)
Bloober Team S.A.’s quoted price sits in the lower half of its reported 52-week range, 20.18% below the high.
€8.72+€0.12 (+1.4%)
Cenit AG’s quoted price sits in the upper half of its reported 52-week range, 11.56% below the high.